← Browse by Condition
Medical Condition

her2 positive early breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04750122 Phase 1, Phase 2
Recruiting

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

Enrollment
46 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →